tiprankstipranks
Novartis, MMV announce data for Phase II/III CALINA study of Coartem
PremiumThe FlyNovartis, MMV announce data for Phase II/III CALINA study of Coartem
8d ago
Novartis reports FDA approves Lutathera for pediatric GEP-NETs
PremiumThe Fly
Novartis reports FDA approves Lutathera for pediatric GEP-NETs
9d ago
Novartis Q1 Results Surge, 2024 Outlook Brightens
PremiumCompany Announcements
Novartis Q1 Results Surge, 2024 Outlook Brightens
9d ago
Novartis announces data from the ALITHIOS study of Kesimpta
PremiumThe FlyNovartis announces data from the ALITHIOS study of Kesimpta
15d ago
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
PremiumThe Fly
Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study
17d ago
MorphoSys board recommends shareholders accept Novartis offer
PremiumThe Fly
MorphoSys board recommends shareholders accept Novartis offer
21d ago
Novartis announces new data on twice-yearly Leqvio in ASCVD
PremiumThe FlyNovartis announces new data on twice-yearly Leqvio in ASCVD
25d ago
Novartis reports Fabhalta receives positive CHMP opinion
PremiumThe Fly
Novartis reports Fabhalta receives positive CHMP opinion
1M ago
BioNTech names Annemarie Hanekamp as Chief Commercial Officer
PremiumThe Fly
BioNTech names Annemarie Hanekamp as Chief Commercial Officer
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100